Jalilivand, Sahar
Izadirad, Mehrdad
Vazifeh Shiran, Nader
Gharehbaghian, Ahmad
Naserian, Sina
Article History
Received: 12 March 2024
Accepted: 29 April 2024
First Online: 22 May 2024
Declarations
:
: Dr. Sina NASERIAN is the CEO of CellMedEx company. The rest of the authors declare that they have no competing interests.
: BM-MSCs were obtained from the Royan Stem Cell Bank (Tehran, Iran). This activity with the title of “Evaluation of long non-coding RNAs expression (HOTAIR, MALAT1, H19) in HL-60 cell line after treatment with normal BM-MSC derived exosomes” was approved by the Biomedical Research Ethics Committee of the Vice-Chancellor in Research Affairs, Shahid Beheshti University of Medical Sciences under ethical number: IR.SBMU.RETECH.REC.1401.512. (Approval date: 2022/11/13).